Newsroom | 49097 results

DUBLIN--(BUSINESS WIRE)--The "Europe Image-Guided Drug Delivery Market: Focus on Technology Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Europe image-guided drug delivery market is projected to reach $284.1 million by 2035 from $13.7 million in 2024, growing at a CAGR of 32.01% during the forecast period 2025-2035. The growing use of IGDD systems throughout Europe and developments in sophist...

DUBLIN--(BUSINESS WIRE)--The "Bipolar Disorder: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM and provides an Excel-based forecast model for the Bipolar Disorder market through 2034. The bipolar disorder market is crowded with inexpensive generic products and off-label drugs. There are currently not many effective treatments targeting bipolar depression, warranting targeted drug development. In the late-stage pipeline...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Dec. 31, 2025 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 10 individuals hired by Sarepta in the fourth quarter of 2025. The equity awards were approved in accordance with Nasdaq Listing Rule...

DUBLIN--(BUSINESS WIRE)--The "Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for i...

DUBLIN--(BUSINESS WIRE)--The "Lupus Nephritis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on num...

DUBLIN--(BUSINESS WIRE)--The "IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering. This report provides top line data relating to the clinical trials on IgA Nephropathy (Berger's Disease). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), ph...

TORONTO--(BUSINESS WIRE)--New data from Phoenix found 38% of Canadians don’t consider their health and wellness goals to be enough of a reason to book a doctor’s appointment....

DUBLIN--(BUSINESS WIRE)--The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ResearchAndMarkets.com's offering. Artificial Intelligence (AI) and Machine Learning (ML) are rapidly reshaping the clinical trials landscape, driving innovation in how research is designed, conducted and evaluated. This course is aimed at anyone working in clinical research, clinical operations, data management, regulatory and compliance, a...

SAN DIEGO--(BUSINESS WIRE)--Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® drug discovery platform, announced today it has been awarded a research grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to further advance its data-driven drug discovery capabilities. Omics technologies enable comprehensive characterization of cellular systems. This means phenot...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of John P. “Jack” Kenny to its Board of Directors....